XETRA - Delayed Quote EUR
Biotest Aktiengesellschaft (BIO.DE)
43.00
+0.20
+(0.47%)
At close: May 30 at 5:36:02 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | 712.14M | -- |
| Low Estimate | -- | -- | 712.14M | -- |
| High Estimate | -- | -- | 712.14M | -- |
| Year Ago Sales | -- | -- | 726.2M | -- |
| Sales Growth (year/est) | -- | -- | -1.94% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BIO.DE | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.48% | 7.55% | 13.96% |
Related Tickers
NVV1.DE Novavax, Inc.
7.85
-0.53%
88Q.DE 4basebio PLC
13.20
0.00%
7V0.DE Darwin AG
30.20
-0.66%
AYJ.DE Valneva SE
2.7880
-3.46%
NP5.DE Newron Pharmaceuticals S.p.A.
7.97
+1.92%
9VC.DE Atai Life Sciences N.V.
1.9960
-4.08%
VX1.DE Vertex Pharmaceuticals Incorporated
389.15
-0.97%
BBZA.DE BB Biotech AG Ord
31.55
-0.32%
HPHA.DE Heidelberg Pharma AG
3.3800
-5.59%
FYB.DE Formycon AG
23.70
+3.27%